An international collection of information from leading researchers resulting from the WHO meeting in April 1986 is presented on how to provide safe blood and blood products in relation to AIDS. An overview is given of the LAV/HTLV-III virus together with its expression and natural history. Next is a comprehensive cover of i) industry's data on the use of special procedures to inactivate the AIDS virus during the manufacture of plasma derivatives...